No Data
Morgan Stanley Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $27
Ardent Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Ardent Health Partners, Inc. (ARDT)
Seven Ardent Health Facilities Earn 2024 Leapfrog Top Hospital Award for Outstanding Quality and Safety
J.P. Morgan Maintains Ardent Health Partners(ARDT.US) With Hold Rating, Raises Target Price to $20
Beyond The Numbers: 6 Analysts Discuss Ardent Health Partners Stock
nolan ratchford : agreed, its a great stock, extremely undervalued currently and the business is solid and relatively new. people are overlooking this right now. as we see the bulls retreat, this is the stock that will rise! at this price, its a great pick up. too 35$ in 2025